0
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Association of coinfections with differences in outcomes across COVID-19 variants

, MDORCID Icon, , DO, , PhD, , MPH, , PhD, , MD, , MD & , MD show all
Received 02 May 2024, Accepted 02 Jul 2024, Published online: 31 Jul 2024

  • Iuliano AD, Brunkard JM, Boehmer TK, et al. Trends in disease severity and health care utilization during the early omicron variant period compared with previous SARS-CoV-2 high transmission periods - United States, December 2020-January 2022. MMWR Morb Mortal Wkly Rep. 2022;71(4):146–152. doi:10.15585/mmwr.mm7104e4.
  • Corriero A, Ribezzi M, Mele F, et al. COVID-19 variants in critically ill patients: a comparison of the delta and omicron variant profiles. Infect Dis Rep. 2022;14(3):492–500. doi:10.3390/idr14030052.
  • Sigal A, Milo R, Jassat W. Estimating disease severity of Omicron and Delta SARS-CoV-2 infections. Nat Rev Immunol. 2022;22(5):267–269. doi:10.1038/s41577-022-00720-5.
  • Musuuza JS, Watson L, Parmasad V, Putman-Buehler N, Christensen L, Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis. PLoS One. 2021;16(5):e0251170. doi:10.1371/journal.pone.0251170.
  • Patton MJ, Orihuela CJ, Harrod KS, et al. COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation. Crit Care. 2023;27(1):34. doi:10.1186/s13054-023-04312-0.
  • Weidmann MD, Berry GJ, Zucker JE, Huang S, Sobieszczyk ME, Green DA. Bacterial pneumonia and respiratory culture utilization among hospitalized patients with and without COVID-19 in a New York City Hospital. J Clin Microbiol. 2022;60(7):e0017422. doi:10.1128/jcm.00174-22.
  • Suleiman AS, Islam MA, Akter MS, Amin MR, Werkneh AA, Bhattacharya P. A meta-meta-analysis of co-infection, secondary infections, and antimicrobial resistance in COVID-19 patients. J Infect Public Health. 2023;16(10):1562–1590. doi:10.1016/j.jiph.2023.07.005.
  • Walkey AJ, Kumar VK, Harhay MO, et al. The Viral Infection and Respiratory Illness Universal Study (VIRUS): an international registry of coronavirus 2019-related critical illness. Crit Care Explor. 2020;2(4):e0113. doi:10.1097/CCE.0000000000000113.
  • Embi PJ, Levy ME, Naleway AL, et al. Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults - nine states, January-September 2021. MMWR Morb Mortal Wkly Rep. 2021;70(44):1553–1559. doi:10.15585/mmwr.mm7044e3.
  • Mutnal MB, Johnson S, Mohamed N, et al. Surveillance genome sequencing reveals multiple SARS-CoV-2 variants circulating in central Texas, USA, with a predominance of delta variant and review of vaccine breakthrough cases. J Med Virol. 2022;94(3):937–944. doi:10.1002/jmv.27373.
  • Lauring AS, Tenforde MW, Chappell JD, et al. Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. BMJ. 2022;376:e069761. doi:10.1136/bmj-2021-069761.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.